Evidence map›Paper›PMID 30251219›Full record

ReviewJournal of cardiovascular translational research2019

The Exosome: a New Player in Diabetic Cardiomyopathy.

Lichan Tao, Jia Shi, Xiaoyu Yang, Ling Yang, Fei Hua

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of cardiovascular translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Diabetes complications and extracellular vesicle therapy.Reviews in endocrine & metabolic disorders · 2022
    Review
  9. Extracellular Vesicles in Type 1 Diabetes: A Versatile Tool.Bioengineering (Basel, Switzerland) · 2022
    Review
  10. Heart failure in diabetes.Metabolism: clinical and experimental · 2021
    Review
  11. Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lichan TaoDepartment of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China.
Jia ShiDepartment of Neurosurgery, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China.
Xiaoyu YangDepartment of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China.
Ling YangDepartment of Cardiology, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China. jsczyangling@163.com.
Fei HuaDepartment of Endocrinology, The Third Affiliated Hospital of Soochow University, Changzhou City, 213003, China. czhuafei@vip.sina.com.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic cardiomyopathy (DCM) or diabetes-induced cardiac dysfunction is a direct consequence of uncontrolled metabolic syndrome and occurs worldwide. However, the underlying cellular and molecular mechanisms remain poorly understood. Recently, exosomes have attracted considerable interest for their use as efficient, targeted, and non-immunogenic delivery systems for biological molecules or pharmacotherapies. This review will summarize the fast-developing field of the regulation and function of exosomes in DCM, affording valuable insights and therapeutic opportunities in combatting diabetes-related cardiac disorder for modern human health.

Indexed as

AnimalsCell ProliferationDiabetic CardiomyopathiesExosomesHumansMyocytes, CardiacRecovery of FunctionRegenerationSignal TransductionStem Cell TransplantationDiabetic cardiomyopathyExosomes

Identifiers

PMID30251219
OpenAlexW2894520022

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.